Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04029922
Title Study of MT-5111 in HER2-positive Solid Tumors (MT-5111)
Acronym MT-5111
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | AUS


No variant requirements are available.